Breadcrumb AMCP.org Policy & Advocacy Letters, Statements & Analysis AMCP Submits Comments to FDA Advocating for Clarification of FDAMA Section 114 and the Creation of a Safe Harbor for Preapproval Information Exchange AMCP Submits Comments to FDA Advocating for Clarification of FDAMA Section 114 and the Creation of a Safe Harbor for Preapproval Information Exchange 4/19/17 Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page AMCP Comments Re FDA Manufacturer Communications with Payors_FINAL.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page